Pharmacological inhibition of protein kinase C (PKC)zeta downregulates the expression of cytokines involved in the pathogenesis of chronic obstructive pulmonary disease (COPD)

导出原文传递

翻译打印收藏纠错

作者： Abdel-Halim, Mohammad ^[1] ; Darwish, Sarah S. ^[2] ; ElHady, Ahmed K. ^[3] ; Hoppstaedter, Jessica ^[4] ; Abadi, Ashraf H. ; Hartmann, Rolf W. ; Kiemer, Alexandra K. ; Engel, Matthias

作者单位： Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany ^[1] Univ Saarland, Pharmaceut & Med Chem, Saarbrucken, Germany ^[2] Univ Saarland, Pharmaceut Biol, Saarbrucken, Germany ^[3] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Chem, Cairo, Egypt ^[4]

关键词 NF-kappa B COPD PKC-zeta Pharmacological target qPCR array

发布时间 2017-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of pharmaceutical sciences

2016年93卷

405-409页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacological inhibition of protein kinase C (PKC)zeta downregulates the expression of cytokines involved in the pathogenesis of chronic obstructive pulmonary disease (COPD)

European journal of pharmaceutical sciences

相似文献

European journal of pharmaceutical sciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacological inhibition of protein kinase C (PKC)zeta downregulates the expression of cytokines involved in the pathogenesis of chronic obstructive pulmonary disease (COPD)

European journal of pharmaceutical sciences

相似文献

European journal of pharmaceutical sciences

相关期刊

检索历史清除